top of page

News & Insights

Beyond Symptoms: Systemic Stress as a Driver of Maternal and Kidney Health Disparities

Beyond Symptoms: Systemic Stress as a Driver of Maternal and Kidney Health Disparities

Beyond Symptoms: Systemic Stress as a Driver of Maternal and Kidney Health Disparities

Sickle Cell Disease and the Evidence Gap: Why Better Data Means Better Asset Value

Sickle Cell Disease and the Evidence Gap: Why Better Data Means Better Asset Value

Sickle Cell Disease and the Evidence Gap: Why Better Data Means Better Asset Value

"The Treatment Exists But Not for Patients Like Me”: The Evidence Gap Behind Cancer Care Inequality

"The Treatment Exists But Not for Patients Like Me”: The Evidence Gap Behind Cancer Care Inequality

"The Treatment Exists But Not for Patients Like Me”: The Evidence Gap Behind Cancer Care Inequality

Prostate Cancer PSA Testing Updates - What’s Changing and What to Do Next

Prostate Cancer PSA Testing Updates - What’s Changing and What to Do Next

Prostate Cancer PSA Testing Updates - What’s Changing and What to Do Next

A Biomarker Blood Test Could Tell You If Your Treatment Works. But Most Patients Never Get It.

A Biomarker Blood Test Could Tell You If Your Treatment Works. But Most Patients Never Get It.

A Biomarker Blood Test Could Tell You If Your Treatment Works. But Most Patients Never Get It.

Nowhere Else to Go: Patients, Pressure, and the Breaking Point for Community Health Centres

Nowhere Else to Go: Patients, Pressure, and the Breaking Point for Community Health Centres

Nowhere Else to Go: Patients, Pressure, and the Breaking Point for Community Health Centers

“I Almost Quit the Trial”: Why Clinical Research Is Losing Patients Before Science Ever Fails

“I Almost Quit the Trial”: Why Clinical Research Is Losing Patients Before Science Ever Fails

“I Almost Quit the Trial”: Why Clinical Research Is Losing Patients Before Science Ever Fails

The Hidden Reason Cardiovascular AI Trials Succeed or Fail (And It Starts With Patients)

The Hidden Reason Cardiovascular AI Trials Succeed or Fail (And It Starts With Patients)

The Hidden Reason Cardiovascular AI Trials Succeed or Fail (And It Starts With Patients)

The Quiet Collapse of Early-Stage Biotech And the Value We Pretend Isn’t Lost

The Quiet Collapse of Early-Stage Biotech And the Value We Pretend Isn’t Lost

The Quiet Collapse of Early-Stage Biotech And the Value We Pretend Isn’t Lost

Decentralized Trials

Decentralized Trials

When Decentralized Trials Meet Real Life: A Patient’s Wake-Up Call

The Investigator-Led Proof-of-Concept Model: Faster, Leaner, and More Real-World by Design

The Investigator-Led Proof-of-Concept Model: Faster, Leaner, and More Real-World by Design

The Investigator-Led Proof-of-Concept Model: Faster, Leaner, and More Real-World by Design

Stop Outsourcing Your Brain: Why Sponsors Should Architect Their Own Proof-of-Concept Trials

Stop Outsourcing Your Brain: Why Sponsors Should Architect Their Own Proof-of-Concept Trials

Stop Outsourcing Your Brain: Why Sponsors Should Architect Their Own Proof-of-Concept Trials

Most Alzheimer’s POC trials don’t fail. They leave patients waiting on “maybe.”

Most Alzheimer’s POC trials don’t fail. They leave patients waiting on “maybe.”

Why a $10M Full-Service CRO POC May Be the Wrong Investment for Early & Mid-Stage Teams

Expectation vs. Reality in Clinical Partnerships

Expectation vs. Reality in Clinical Partnerships

Expectation vs. Reality in Clinical Partnerships

Biosimilars reimagined: faster, smarter, patient-ready

Biosimilars reimagined: faster, smarter, patient-ready

Biosimilar Development in 2026 and Beyond

How data-driven health equity can fix the science and speed access

How data-driven health equity can fix the science and speed access

Building Health Equity Into Clinical Research Strategy: Turning Mission Into Measurable Impact

Turning compliance challenges into clinical trial strengths.

Turning compliance challenges into clinical trial strengths.

Clinical Trial Compliance Challenges and How to Overcome Them

Proof That Macrobiological Equity Strengthens Clinical Trials Through Real-World Application

Proof That Macrobiological Equity Strengthens Clinical Trials Through Real-World Application

Proof That Macrobiological Equity Strengthens Clinical Trials Through Real-World Application

Embedding Macrobiological Equity into Clinical Trial Design through Clinicoequity

Embedding Macrobiological Equity into Clinical Trial Design through Clinicoequity

Embedding Macrobiological Equity into Clinical Trial Design through Clinicoequity

Designing trials that reflect the real world.

Designing trials that reflect the real world.

How Macrobiological Inequities Shape Clinical Trial Design

2 3

bottom of page